Remove Biotech Remove Culture Change Remove Operations
article thumbnail

Navigating leadership transitions: Empowering leaders for success

Kotter Inc.

As Starbucks and Chipotle navigate CEO transitions, Nick Petschek of Kotter shares how organisations can empower their leaders during leadership changes.

article thumbnail

Building Adaptability in the Pharmaceutical Industry

Kotter Inc.

The post Building Adaptability in the Pharmaceutical Industry appeared first on Kotter International Inc.

Biotech 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Beyond the deal: unlocking sustainable success in pharma M&A

Kotter Inc.

The post Beyond the deal: unlocking sustainable success in pharma M&A appeared first on Kotter International Inc.

Biotech 52
article thumbnail

Outmaneuver Uncertainty: How Adaptable Organizations Win in the Long Run

Kotter Inc.

As leaders look toward the future, the companies that will outpace and outperform their competitors will be those that can embrace and scale adaptability and agility in their operations.

article thumbnail

Leading in Uncertainty

Kotter Inc.

Uncertainty isnt necessarily badtimes of change and disruption are filled with opportunities to do things differently and better. If new regulatory requirements are disrupting the way the business has operated, it will do so for the whole industry and create an opportunity to shift the landscape and come out on top.

article thumbnail

Meaningful Integration: Building culture and success in pharma M&A

Kotter Inc.

After the pharmaceutical industrys muted mergers and acquisitions (M&A) landscape in 2024, Nick Petschek, EMEA MD at Kotter International suggests many expect M&A to pick back up in 2025.

Biotech 52
article thumbnail

Key Challenges Facing the Pharma Industry in 2025

Kotter Inc.

In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Gaurav Gupta, managing director and head of R&D at Kotter, details the types of regulatory pressures and factors surrounding rising R&D costs that will affect the pharmaceutical industry.

Manager 52